Use of Investigational Drug, Agent, Device Policies

Policies related to the Use of Investigational Devices, Drugs and/or Agents

The Framingham Heart Study may not be used as a testing ground for demonstration of safety or efficacy of an investigational agent or device.

The Framingham Heart Study will only consider the administration of drugs if they have no more than minimal risk for a serious adverse event.

Last Updated: January 11, 2022